Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Bullboard (NDAQ:SAVA)

View:
1 2 3 Next
Post by TradeSni38per91on Nov 26, 2024 9:41am

SAVA - The Short-Sellers Have Been All Over This One... But

I’ve been watching $SAVA for a while, and I gotta say, this stock is straight-up volatile. We all know the short-sellers have been hammering it — they’ve been calling out potential data manipulation ...more  
28
Post by ProfitGrid8448on Nov 26, 2024 9:32am

$SAVA - Watching This One Closely, Big Volatility Ahead!

Yo, anyone else keeping an eye on $SAVA right now? It's been a rollercoaster, man. This thing is like the ultimate case study for biotech risk vs. reward. Last few weeks have been nuts — one ...more  
27
Post by BlazeHunter44on Nov 25, 2024 5:57pm

A Biotech Train Wreck

Oof, SAVA is in the dumps after an Alzheimer’s trial flop. Biotech’s a gamble, and this one’s taken a big L. If they rework the pipeline, there might be a bounce—but for now? Hard pass.
30
Post by whytestockson Nov 25, 2024 5:30pm

Bronstein, Gewirtz & Grossman, LLC Announces an Investigatio

JUST IN: $SAVA Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Stockholders to Learn More About the InvestigationNEW YORK CITY ...more  
23
Post by EagleGains54on Nov 25, 2024 2:49pm

Bullish Prospects for $SAVA and $BOLT.CN

$SAVA continues to show strong fundamentals as clinical trials progress in its Alzheimer’s treatment pipeline. Investor confidence grows with positive data expected. Meanwhile, $BOLT.CN benefits from ...more  
28
Post by TradeVision2001on Nov 25, 2024 12:22pm

Strong Fundamentals in $SAVA and $BOLT.CN

$SAVA’s innovative biotech pipeline positions it as a leader in addressing critical neurodegenerative diseases. Solid cash reserves support its long-term growth. $BOLT.CN rides the wave of metals ...more  
27
Post by PivotMaster77on Nov 25, 2024 11:49am

Cassava Sciences: Alzheimer’s Trial Setback

A failed Alzheimer’s drug trial has led to a significant decline in Cassava Sciences’ stock, as investors reassess the company’s future prospects.
24
Post by Iseneschalon Nov 25, 2024 9:30am

SAVA....and The Shorts win

Bad News for Bonzo the Bagholder
16
Post by 10QKingon Nov 25, 2024 9:14am

SAVA Borrow Fee Sky High with 50% Float Sold Short Cover

SAVA Borrow Fee Sky High with 50% Float Sold Short Cover Buy to Cover Shorty
24
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities